Cancer Types Most Studied in Relation to GLP-1 Therapy Current peer-reviewed evidence has focused on the following obesity- and metabolic-related malignancies: Endometrial cancer (consistently demonstrating the strongest protective signal) Ovarian cancer Colorectal cancer Breast cancer (particularly post-menopausal) Meningioma Hepatobiliary cancers (liver and bile duct) Pancreatic cancer Gastric cancer Thyroid cancer Multiple myeloma A Note on Metabolic Dysfunction as the Root of Cancer Predisposition One of the most clinically meaningful insights emerging from the GLP-1 cancer research is the reframing of cancer risk as fundamentally a metabolic problem
After combining the amounts measured for the known FXR-antagonistic BAs, we also showed that the percentage of T(/)MCA, (T/G)UDCA, and (T)HDCA in the gallbladder bile was significantly increased in MMI + T3-5d mice compared to MMI mice (Fig
This holistic approach ensures that as your body shrinks, you remain strong and healthy
Research Disclaimer For laboratory and scientific research use only
You will receive an email notification as soon as your licensed provider has reviewed your case and made a prescribing decision
Weight loss stabilizes after 12 to 18 months, but insulin sensitivity, blood sugar control, blood pressure, and lipid levels remain improved
